Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Podebrady

5 clinical trials in Podebrady, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Podebrady at a glance
5
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Podebrady

Open in trial search
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:CzechiaCzechia
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Arteriosclerosis

Not yet recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:Levonorgestrel
  • Sponsor:Chemo Research S.L.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Podebrady

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on Atrial Fibrillation management are evaluating novel therapeutic approaches. These studies examine the safety and efficacy of new anticoagulation treatments for patients with irregular heart rhythms.

  • Blood Clot Prevention
  • Heart Rhythm Management
  • Alternative Anticoagulation Options

Research includes comparative studies between abelacimab and established treatments, particularly focusing on patients who cannot use traditional oral anticoagulants.

02 Safety Studies

Current trials are investigating bleeding risk management in patients with cardiac arrhythmias. These studies specifically compare different anticoagulation approaches to determine optimal treatment strategies.

  • Bleeding Risk Assessment
  • Treatment Tolerance
  • Patient Safety Profiles

Research emphasizes the evaluation of major and clinically relevant non-major bleeding events in cardiovascular patients.

03 Specialized Patient Care

Advanced research targeting high-risk cardiac patients who require alternative treatment approaches. Studies focus on preventing stroke and other systemic complications in specific patient populations.

  • Stroke Prevention
  • Alternative Therapies
  • Personalized Treatment Approaches

The research aims to expand treatment options for patients who cannot use conventional anticoagulation therapies.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.